10 Fibromyalgia Clinical Trials in Tucson, AZ (2026)

Q: How do I join a clinical trial in Tucson?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Tucson research site will contact you.

Recruiting Fibromyalgia Studies in Tucson

NCT01915511Recruiting

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

The Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry started recruiting in 2014 with the objective of studying Idiopathic Pulmonary Fibrosis. In 2018, the registry expanded to inc...

Tucson, AZ3,000 participantsDuke University

View Study Details

NCT05862272Recruiting

A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

The purpose of this clinical trial to characterize changes in bone mineral density during continuous treatment with relugolix combination tablet for up to 48 months (4 years) and 1 year of post-treatm...

Tucson, AZPHASE31,000 participantsSumitomo Pharma Switzerland GmbH

View Study Details

NCT05548283Recruiting

Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study

The purpose of this study is to look at pulmonary exacerbations in people with cystic fibrosis (CF) that need to be treated with antibiotics given through a tube inserted into a vein (intravenous or I...

Tucson, AZPHASE4730 participantsChris Goss

View Study Details

NCT07398417Recruiting

Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design

The study is a Phase 3, double-blind, placebo-controlled, randomized withdrawal study to assess the efficacy and safety of AXS-14 in the management of fibromyalgia....

Tucson, AZPHASE3620 participantsAxsome Therapeutics, Inc.

View Study Details

NCT06654752Recruiting

Streamlined Treatment of Pulmonary Exacerbations in Pediatrics

The STOP PEDS RCT is a multicenter, parallel, open label randomized controlled trial evaluating the long-term (one year) and short-term safety and efficacy of two antibiotic treatment strategies for t...

Tucson, AZNA430 participantsUniversity of Washington, the Collaborative Health Studies Coordinating Center

View Study Details

NCT06504589Recruiting

A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

The REACH study is for people with CF who do not take cystic fibrosis transmembrane conductance regulator (CFTR) modulators. The goal of the REACH study is to collect research data, including health d...

Tucson, AZ400 participantsNicole Hamblett

View Study Details

NCT04176198Recruiting

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

This study is a Phase 1/2, multicenter, dose-escalation, open-label trial to assess safety, tolerability, pharmacokinetics and pharmacodynamics of nuvisertib (TP-3654) in patients with intermediate or...

Tucson, AZPHASE1240 participantsSumitomo Pharma America, Inc.

View Study Details

NCT07610837Recruiting

Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis

The purpose of this study is to evaluate the safety, tolerability, and pharmacodynamic effects of AZD2389 in adult participants with steatotic liver disease (SLD) and advanced fibrosis....

Tucson, AZPHASE2104 participantsAstraZeneca

View Study Details

NCT06747858Recruiting

Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis

ARCT-032-02 is a Phase 2, open-label, multicenter, multiple-ascending dose study of ARCT-032 in adults with CF who are not eligible for CFTR modulator therapy or are not taking CFTR modulators due to ...

Tucson, AZPHASE233 participantsArcturus Therapeutics, Inc.

View Study Details

NCT05248230Recruiting

4D-710 in Adult Patients With Cystic Fibrosis

This is a Phase 1/2 multicenter, open-label, single dose trial of 4D-710 investigational gene therapy in adults with cystic fibrosis....

Tucson, AZPHASE230 participants4D Molecular Therapeutics

View Study Details

About Fibromyalgia Clinical Trials in Tucson

Fibromyalgia is a condition characterized by widespread musculoskeletal pain, fatigue, sleep disturbance, and cognitive difficulties. It affects about 2-4% of the population, predominantly women. Treatment includes medications, exercise, stress management, and cognitive behavioral therapy.

There are currently 10 fibromyalgia clinical trials recruiting participants in Tucson, AZ. These studies are seeking a combined 6,587 participants. Research is being sponsored by Duke University, Sumitomo Pharma Switzerland GmbH, Chris Goss and 7 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Fibromyalgia Clinical Trials in Tucson — FAQ

Are there fibromyalgia clinical trials in Tucson?

Yes, there are 10 fibromyalgia clinical trials currently recruiting in Tucson, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Tucson?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Tucson research site will contact you about next steps.

Are clinical trials in Tucson free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Tucson studies also compensate for your time and travel.

What fibromyalgia treatments are being tested?

The 10 active trials in Tucson are testing new therapies including novel drugs, biologics, and treatment approaches for fibromyalgia.

Data updated October 12, 2026 from ClinicalTrials.gov